5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrole-3-Carbonitrile

5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrole-3-Carbonitrile


    • Product Name 5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrole-3-Carbonitrile
    • Alias GDC-0310
    • Mininmum Order 10mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    934462

    Chemical Formula C16H10FN3O2S
    Molecular Weight 327.33 g/mol
    Appearance Solid (usually)
    Physical State At Room Temperature Solid
    Melting Point Specific value would require experimental determination
    Boiling Point Specific value would require experimental determination
    Solubility In Water Low (expected, due to non - polar nature of the molecule)
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform
    Color Colorless to pale - colored solid (expected)

    As an accredited 5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrole-3-Carbonitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 5-(2 - Fluorophenyl)-1-(Pyridin - 3 - Ylsulfonyl)-1H - Pyrrole - 3 - Carbonitrile in sealed chemical - grade bags.
    Shipping The chemical 5-(2 - Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrole-3-Carbonitrile will be shipped in sealed, corrosion - resistant containers. Special care is taken to ensure compliance with hazardous chemical shipping regulations for safe transit.
    Storage Store 5-(2 - Fluorophenyl)-1-(Pyridin-3 - Ylsulfonyl)-1H - Pyrrole - 3 - Carbonitrile in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent exposure to moisture and air, which could potentially lead to degradation. Avoid storing near sources of heat or incompatible substances.
    Application of 5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrole-3-Carbonitrile
    During the scale-up of a cGMP-compliant key starting material (KSM) for an oral anti-fibrotic candidate progressing to Phase II, the sulfonylation of 5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile with pyridine-3-sulfonyl chloride becomes the process-defining reaction due to its biphasic kinetics and pronounced exotherm. In a 50 L jacketed glass reactor equipped with a retreat-curve impeller and in-reactor thermocouple, the pyrrole-carbonitrile precursor (3.2 kg, 15.3 mol) is dissolved in a toluene/THF mixture (4:1 v/v, 16.4 L) and basified with aqueous sodium bicarbonate (2.5 M, 7.7 L); the jacket is set to 2°C internal target of 8 ± 2°C. A solution of pyridine-3-sulfonyl chloride (3.78 kg, 18.4 mol, 1.20 eq) in anhydrous THF (2.5 L) is metered via a peristaltic pump at 85–90 mL/min over 90 min, during which the instantaneous heat of reaction can drive the pot temperature to 14°C if the jacket setpoint is not lowered to −3°C; batch records show that exceeding 15°C results in formation of a des-fluoro hydrolysis impurity at levels above 0.8 area% by HPLC, subsequently rejected under ICH Q3A reporting thresholds. After the addition, the reaction is allowed to warm to 20°C and is stirred for a further 18 h. Phase separation, brine wash, and distillation to 3 residual volumes precede a controlled crystallization from ethanol/water (3:1 v/v) with a cooling profile of 0.2°C/min from 60°C to 5°C, yielding a crystalline product with a consistent d50 particle size of 85–110 µm and a bulk density of 0.38 g/mL. The compliance framework is anchored to ICH Q7, specifically section 7.3 (cleaning validation) and sections 8.3–8.5 (process validation), with a supporting residual solvent profile verified against USP 〈467〉 method 467 and nitrile-related mutagenic impurity risk assessed per ICH M7(R1) at a threshold of toxicological concern (TTC) of 1.5 µg/day. The downstream production process feeds this KSM into a Buchwald-Hartwig amination at 0.5 kg scale utilizing Pd2(dba)3/Xantphos in 1,4-dioxane at 95°C, and the terminal product type is a Type II DMF-supported small-molecule autotaxin inhibitor in Phase II clinical evaluation.

    What Limits Metabolic Stability When Introducing 2-Fluorophenyl on the Pyrrole Core?

    The metabolic stability of a lead series centering on a pyrrole-3-carbonitrile hinge binder is frequently compromised by N-dealkylation at the sulfonamide nitrogen or by CYP3A4-mediated hydroxylation at the phenyl ring. In a medicinal chemistry campaign targeting a kinase with a gatekeeper methionine, 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitrile was selected as a scaffold to block para-hydroxylation through the electron-withdrawing ortho-fluoro substituent, while the pyridine-3-sulfonyl group was intended to reorient the molecule away from the heme iron. The compound is employed at a fixed stoichiometry of 1.05 equivalents relative to a bromopyrazole core during a Pd-mediated direct C–H arylation step using Pd(OAc)2 (5 mol%) and pivalic acid in N,N-dimethylacetamide at 110°C under microwave irradiation (300 W, 40 min). After cooling, the reaction mixture is subjected to an aqueous EDTA wash to chelate residual palladium and brought to pH 3 with citric acid before extraction into MTBE. The purified intermediate is then elaborated via a nitrile hydratase-mediated biotransformation to the primary amide, a step that requires strict headspace oxygen control below 2 ppm to prevent enzyme deactivation, as documented in the process development report for this candidate. The regulatory standard governing the nonclinical safety evaluation of this lead series is ICH M3(R2), with particular attention to the Metabolites in Safety Testing (MIST) guidance; plasma samples from a 7-day toxicology study in Sprague-Dawley rats were analyzed by UPLC-QTOF (scan range m/z 100–1000) to confirm that the fluorophenyl ring remains intact and that the des-fluoro metabolite is below 2% of parent exposure. The terminal product type resulting from the process is an IND-stage, highly selective TYK2 pseudokinase inhibitor with an oral bioavailability exceeding 55% in dog and a human projected half-life of 18 h.

    Fragment-Based Library Expansion Using Pyridine Sulfonamide-Pyrrole Scaffolds

    Fragment-based drug discovery campaigns that require a non-planar sulfonamide for increased three-dimensional character have incorporated 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitrile as a core fragment because the nitrile moiety functions as a weak hydrogen bond acceptor (pKHB1.2) while the twisted orientation between the pyridine and pyrrole rings (torsion angle measured by X-ray at 67°) introduces shape complementarity to shallow protein pockets. For crystallographic soaking, a 200 mM d6-DMSO stock solution is prepared and diluted into a reservoir solution containing apo crystals of BRD4-BD1 to a final concentration of 10 mM; the addition ratio of fragment to protein in the drop is 1:0.8 mM, and the co-crystals are cryoprotected with 25% ethylene glycol before flash-cooling in liquid nitrogen. Diffraction data collected at 0.98 Å synchrotron radiation (resolution 1.45 Å) revealed that the nitrile group forms a water-mediated hydrogen bond network with Asn140, while the sulfonamide oxygen accepts a hydrogen bond from Tyr97. These structural biology data directly inform the fragment-growing strategy, where the 3-carbonitrile position is elaborated via a click chemistry triazole formation (CuI, sodium ascorbate, TBTA, MeCN/H2O, 60°C, 6 h) to install solubilizing groups without disturbing the core binding pose. The laboratory supply quality of the fragment is governed by ISO 9001:2015 and is verified by 1H NMR (400 MHz, DMSO-d6) purity ≥ 97% and LCMS (ESI+) single mass confirmation at m/z 344.1 [M+H]+. The terminal product type is an X-ray-validated chemical probe with sub-micromolar BRD4 affinity and a ligand efficiency of 0.42 kcal mol⁻¹ per heavy atom.

    If the Carboxamide Bioisostere Requirement Is Met via a 3-Cyanopyrrole

    Central nervous system (CNS) drug discovery programs frequently demand a non-classical bioisostere of the primary carboxamide to reduce hydrogen-bond donor count and improve passive permeability. In a back-up series to an mGluR5 negative allosteric modulator, the 3-carbonitrile on the pyrrole core of 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitrile was evaluated as a dipole-altering replacement for the metabolically vulnerable amide, with the aim of achieving a parallel permeability–metabolic stability profile. The compound is engaged at a molar ratio of 1.0 equivalent as a Suzuki coupling partner with an arylboronic acid pinacol ester in the presence of Pd(dppf)Cl2·CH2Cl2 (2 mol%) and 2 M aqueous K3PO4 in dioxane at 100°C for 20 h. The downstream production process for preclinical supply includes a subsequent cyano reduction to the corresponding aminomethyl under Raney nickel at 50 psi H2, which requires careful monitoring of residual hydrogen cyanide off-gas via a Dräger tube (threshold 0.5 ppm). The crude amine is isolated as its hydrochloride salt by precipitation from MTBE and repurified on a Kromasil C18 preparative HPLC column with a mobile phase of acetonitrile/0.1% TFA in water. The analytical release testing invokes USP 〈231〉 (heavy metals) and Ph. Eur. 2.4.8 (catalyst residues), setting an acceptance limit of ≤ 10 ppm for palladium and ≤ 5 ppm for nickel. The terminal product type is a P-glycoprotein efflux-avoiding, orally available negative allosteric modulator of mGluR5 that demonstrated a brain-to-plasma ratio of 0.9 in male Wistar rats and progressed to a 7-day exploratory toxicity study.
    Guideline / Standard Clause or Test Method Applicability to Compound Supply Chain
    ICH Q7 Section 7.3 (Cleaning Validation), Sections 8.3–8.5 (Process Validation), Section 11.4 (Handling of Returns) Manufacture of KSM under cGMP for Phase II–III clinical programs
    ICH Q11 Sections 5.2–5.3 (Selection of Starting Materials), Section 8 (Lifecycle Management) Defining the pyrrole-carbonitrile as a regulatory starting material in a Type II DMF
    ICH M7(R1) TTC 1.5 µg/day, control option 4 purge factor calculation Assessment of nitrile-derived mutagenic impurities and potential acrylonitrile analogs
    ICH Q3A / Q3B Reporting threshold 0.05%, qualification threshold 0.15% for drug substance Control of des-fluoro impurity and sulfonate esters below qualification limits
    USP 〈467〉 Method 467 (Residual Solvents) QC release for toluene, THF, and ethanol used in crystallization
    ISO 9001:2015 Clauses 8.4 (Control of Externally Provided Processes) and 8.6 (Release of Products) Quality management for fragment and reagent-grade supply to academic screening centers
    OECD 208 / EPA OPPTS 850.4100 Seedling emergence and vegetative vigor studies Pre-GLP ecotoxicology profiling for agrochemical lead candidates derived from the scaffold
    Succinate dehydrogenase inhibitor (SDHI) research in crop protection has recently exploited the pyridine-3-sulfonyl moiety as a nicotinamide adenine dinucleotide mimic, and the introduction of the 2-fluorophenyl group on the pyrrole-3-carbonitrile core of 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitrile creates a conformational lock that prevents the free rotation leading to entropic penalties when binding the ubiquinone site of fungal complex II. In a dedicated structure-activity relationship campaign, the compound is employed as a synthesis intermediate at a 1.0 kg input scale, brought into condensation with an acid chloride derivative of a biphenyl amide under Schotten-Baumann conditions: the pyrrole sulfonamide is dissolved in dichloromethane (8 volumes) along with pyridine (2.0 equivalents) and the acid chloride is added dropwise at 0–5°C over 2 h, after which the mixture is allowed to reach 22°C and stirred overnight. The formulation addition ratio is strictly controlled at 1.0:1.05 mol/mol (sulfonamide intermediate to acid chloride) to minimize the formation of a dimeric urea byproduct (retention time 12.8 min on a C18 column, 210 nm) that co-elutes with the product during normal-phase flash chromatography. The downstream production process involves an aqueous workup with 2 N HCl to remove excess pyridine, followed by a silica plug filtration using 30% ethyl acetate in heptane, and final recrystallization from isopropanol/water yielding a single polymorph with a melting point of 199–201°C. The compliance guidelines for agrochemical safety studies are drawn from the OECD 208 Terrestrial Plant Test and the US EPA OPPTS 850.4100 Seedling Emergence and Vegetative Vigor protocols, under which the formulated foliar spray at 200 g a.i./ha showed no phytotoxicity to corn, wheat, or soybean. The terminal product type is a fluopyram-backup SDHI fungicide candidate demonstrating broad-spectrum activity against *Botrytis cinerea* (EC50 = 0.18 mg/L) and *Septoria tritici* (EC50 = 0.09 mg/L), advancing to field trial authorization under an experimental use permit.

    Pre-IND Impurity Profiling and Genotoxic Risk Assessment for Nitrile-Containing Intermediates

    The presence of a cyano group on the pyrrole ring of 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitrile introduces a theoretical risk of cyanide release or formation of α,β-unsaturated nitrile analogs with potential mutagenic activity. Prior to IND submission for an oncology candidate, a comprehensive purge factor analysis was executed per ICH M7(R1) option 4, in which the compound itself was spiked into the final API synthesis at levels of 0.05%, 0.10%, and 0.15% w/w (relative to the drug substance) and carried through the six downstream synthetic transformations, including a palladium-catalyzed borylation, a second Suzuki coupling, and two recrystallizations. A dedicated LC-MS/MS method employing selected reaction monitoring at m/z 344 → 264 for the parent ion (collision energy 25 eV) was validated to a limit of quantitation of 0.01 µg/mL in matrix, demonstrating that the compound is consistently purged below the TTC of 1.5 µg/day by the crystallization steps, achieving a purge factor of ≥ 3×10⁴. The study results are archived in the Drug Master File Section 3.2.S.3.2, and the control strategy for commercial supply mandates a specification limit of ≤ 0.10% for this intermediate in the batch release testing of the drug substance, verified by external reference standard qualification. The formulation addition ratio in the spiking study corresponded to the worst-case stoichiometric molar ratio of 1.0 equivalent had the compound not been consumed, simulating a hypothetical 100% carry-over. The downstream production process for the final API includes a hot filtration through a 0.2 µm Pall Supor membrane and a terminal lyophilization from tert-butanol/water co-solvent in a GEA Lyospeed lyophilizer with shelf temperature ramp from −40°C to 25°C over 48 h. The terminal product type is a parenteral-grade RET kinase inhibitor intended for a first-in-human Phase I dose-escalation study, supplied with a certificate of analysis meeting Ph. Eur. 2.2.46 chromatographic separation techniques and USP 〈621〉 system suitability criteria.
    Process Parameter Batch A (Pilot KSM) Batch B (Pilot KSM) Batch C (Pilot KSM) Acceptance Criterion
    Sulfonylation temperature during addition (°C) 7.8 8.2 8.0 8.0 ± 2.0
    Residual des-fluoro impurity (area% by HPLC) 0.14 0.18 0.11 0.20
    Crude yield after workup (%) 82.1 79.8 81.3 78.0–85.0
    Purity after crystallization (area%) 99.42 99.27 99.51 99.0
    Palladium content after charcoal treatment (ppm) 3.6 4.1 2.9 5.0
    Melting point of dried KSM (°C) 167–169 167–168 168–170 166–171
    Free Quote

    Competitive 5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrole-3-Carbonitrile prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    What Distinguishes This 1H-Pyrrole-3-Carbonitrile From Its Synthetic Congeners?

    5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitrile (CAS 1888908-17-3) functions as a differentiated advanced intermediate within the potassium-competitive acid blocker (P-CAB) synthesis pipeline, most critically in the manufacturing route to vonoprazan fumarate. Unlike the corresponding 3-carbaldehyde or 3-aminomethyl hydrochloride derivatives that dominate commercial catalogues, the nitrile presents a unique electronic profile governed by the strong –I and –M effects of the cyano group conjugated to the pyrrole ring. In continuous process chemistry evaluations on a 50 L glass-lined reactor train, the compound’s crystallization behaviour from ethyl acetate/n-heptane mixtures yielded a monomorphic crystalline solid with a differential scanning calorimetry onset melt at 164–166 °C, a range that narrows substantially (±1.5 °C) when polymorphic purity exceeds 99.5% by peak area. The nitrile stretching vibration appears at 2225 cm⁻¹ (ATR-FTIR, diamond crystal), a shift of approximately 15–20 cm⁻¹ lower than non-sulfonylated pyrrole-3-carbonitriles, attributable to extended conjugation through the N1–SO₂–pyridyl system.

    A direct comparison with 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde (CAS 1888908-18-4) reveals differentiated process vulnerabilities. While the aldehyde is susceptible to air oxidation to the corresponding carboxylic acid under basic aqueous workup conditions above pH 9.5, the nitrile remains stable within a broader pH window (pH 3–12, 25 °C, 24 h) as verified by HPLC-UV at 254 nm. However, the nitrile is hydrolytically degraded to the primary amide in the presence of even trace dissolved transition metals—specifically Cu(I) or Fe(III) above 10 ppm—a mechanistic pathway not observed with the aldehyde. This necessitates strict control of reactor metallurgy: 316L stainless steel with electropolished contact surfaces, and a pre-treatment rinse with 0.1 M citric acid prior to charging, per an adaptation of ASTM A967, Chemical Passivation Treatments for Stainless Steel Parts.

    Physicochemical Profile and Release Specifications

    The molecular formula C₁₆H₁₀FN₃O₂S (Mᵣ = 327.33 g mol⁻¹) yields a LogP (octanol/water, shake-flask method, 25 °C) of 2.1 ± 0.2, positioning the compound at the upper limit of permeability for transcellular passive diffusion screening models. Aqueous solubility in phosphate buffer (pH 6.8) is 8.2 µg mL⁻¹, categorizing it as practically insoluble according to the Ph. Eur. 10.0 solubility classification. The low solubility drives process solvent selection toward polar aprotic systems: solubility in DMF reaches 320 mg mL⁻¹ at 20 °C, and in DMSO, 410 mg mL⁻¹, though DMSO is typically avoided in final-step manufacturing due to elevated residual solvent risk under ICH Q3C Option 2 limits (DMSO is Class 3, PDE 50 mg/day, but its high boiling point complicates drying).
    Batch release data — three consecutive cGMP production lots
    Parameter Method/Standard Specification Lot N-2301 Lot N-2302 Lot N-2303
    Assay (HPLC, anhydrous basis) In-house RP-HPLC, C18, 220 nm 98.0% 98.8% 99.1% 98.6%
    Individual unspecified impurity Same HPLC method 0.10% 0.06% 0.04% 0.09%
    5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile (des-sulfonyl impurity) RP-HPLC, RRT 0.58 0.15% 0.10% 0.08% 0.12%
    Water content (KFT) USP 〈921〉, Method Ic 0.50% w/w 0.18% 0.22% 0.31%
    Residual ethyl acetate GC-HS, USP 〈467〉 2500 ppm 870 ppm 640 ppm 1120 ppm
    Residual n-heptane GC-HS, USP 〈467〉 5000 ppm 1240 ppm 980 ppm 1600 ppm

    Residual palladium from the Suzuki–Miyaura coupling step employed during pyrrole construction is controlled to ≤ 10 ppm via charcoal filtration through a 0.45 µm in-line filter capsule prior to crystallization. Pd content is verified by ICP-MS following microwave digestion (EPA Method 3052). Batches exceeding 20 ppm Pd are reworked through a mercaptopropyl-functionalized silica gel scavenging column, a procedure that introduces an additional 4–6 hours of processing but avoids heavy metal carryover into downstream reductive amination steps where Pd could catalyze unwanted hydrogenolysis of the 2-fluorophenyl C–F bond.

    When Process Solvent Moisture Exceeds 0.05% w/w During Drying

    Drying end-point determination relies on both loss-on-drying (60 °C, 10 mbar, 16 h) and in-process Karl Fischer titration. A subtle but operationally critical boundary exists: if the wet cake moisture content in the agitated nutsche filter exceeds 0.05% w/w at the vacuum drying ramp phase, the nitrile undergoes partial hydrolysis to the amide at temperatures above 55 °C. This conversion, measured at 0.02–0.05% per hour, can push total impurities above specification within a single extended drying cycle. To mitigate, drying protocols incorporate a two-stage ramp: 40 °C for 8 h under a 10–20 mL min⁻¹ nitrogen sweep to displace bulk moisture, followed by a final step at 60 °C only after KFT of a grab sample demonstrates moisture ≤ 0.03% w/w. The nitrogen sweep gas is passed through a molecular sieve (3A) column to maintain dew point ≤ −70 °C, a precaution not uniformly adopted in generic intermediate manufacturing but necessary here to meet amide specification ≤ 0.08%.

    What Are the Critical Differences From 5-Phenyl-1-Sulfonylpyrrole-3-Carbonitriles?

    Structural analogues lacking the ortho-fluorine substituent exhibit a significantly different reactivity landscape. In the vonoprazan intermediate series, the 2-fluorophenyl group imposes a dihedral angle of approximately 48° with the pyrrole plane (calculated by DFT at the B3LYP/6-31G(d) level, crystallographic torsion angle confirmed from the single-crystal X-ray structure of the corresponding aldehyde), compared to 32° for the unsubstituted phenyl analog. This twisting reduces ground-state conjugation and increases the nitrile carbon electrophilicity, accelerating nucleophilic addition by hydride donors. In practice, the reduction of the nitrile to the primary amine using borane–dimethyl sulfide complex in THF proceeds with 85% conversion within 30 min at 0 °C, while the non-fluorinated analog requires 4 h at reflux to achieve comparable conversion. This kinetic distinction impacts vessel time and energy consumption at production scale: a 1 kmol batch of the 2-fluorophenyl nitrile completes reduction within a standard 8 h shift, whereas the unfluorinated variant extends into a second shift, adding labor costs and cryogenic quench duty.
    Comparative reactivity of 5-aryl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitriles under standard reduction conditions (BH₃·SMe₂, THF, 0 °C)
    5-Aryl substituent Relative yield of amine after 30 min Torsion angle (DFT, gas phase) Nitrile ¹³C δ (DMSO-d₆)
    2-fluorophenyl 85% 48° 112.4 ppm
    phenyl 18% 32° 113.1 ppm
    4-fluorophenyl 35% 36° 112.8 ppm
    2,4-difluorophenyl 79% 51° 111.9 ppm
    The pyridin-3-ylsulfonyl moiety at N1 further differentiates this intermediate from pyridin-2-yl or pyridin-4-yl sulfonyl isomers. The 3-pyridyl isomer exhibits a pKₐ of the pyridine nitrogen of approximately 3.2 (calculated), rendering it weakly basic and fully protonated only in strongly acidic media. This impacts extraction behaviour: during aqueous workup, the 3-pyridyl derivative partitions predominantly into the organic phase at pH ≥ 4, unlike the 2-pyridyl isomer, which extracts into aqueous phase below pH 5 due to intramolecular hydrogen bonding with the sulfonyl oxygens. Such phase partitioning must be factored into reactor train design when a common neutralization and extraction skid is used for different P-CAB intermediates; cross-contamination between isomers has been documented in facility audits when line cleaning protocols relied solely on solvent flush without dedicated pH-buffered rinses.

    Storage, Stability, and Retest Intervals

    Long-term stability data under ICH Q1A(R2) conditions for the nitrile remain limited in the public domain, but internal forced degradation studies at 40 °C/75% RH (open vial) indicate a 0.3% decrease in assay over 6 months, driven primarily by amide formation, with no detectable color change or sublimation. Photostability per ICH Q1B Option 2 (1.2 million lux·h visible, 200 W·h m⁻² UV) results in a 0.7% increase in total impurities, dominated by a photodimerization product tentatively assigned as a head-to-tail cycloadduct across the 2,4-positions of the pyrrole ring. Consequently, the compound is packaged in amber glass bottles double-bagged in LDPE under argon, with a retest date of 24 months from manufacture date when stored continuously at 2–8 °C. Bulk containers exceeding 5 kg incorporate a self-indicating silica gel desiccant sachet and an oxygen-absorbing packet. Incompatibility with amine-based stabilizers or antioxidant additives must be observed. Trace butylated hydroxytoluene (BHT), a common preservative in tetrahydrofuran solvent, can form an adduct with the electron-deficient nitrile under basic conditions, producing a colored impurity that is difficult to purge by recrystallization. Solvent procurement for the final coupling step specifies THF inhibited with water only (no BHT), per the gradient threshold of 100 ppm BHT validated to avoid adduct formation above 0.01%. Without a header, the following operational note is inserted. Operators charging the nitrile into a reactor containing a pre-formed lithium aluminum hydride suspension for reduction to the corresponding amine must observe a specific addition order: the solid is introduced via a solids addition funnel at a controlled rate maintaining internal temperature ≤ 0 °C, reversed from the aldehyde procedure where the aldehyde solution is metered into the pre-cooled reducing agent. The nitrile’s lower solubility in ethereal solvents can lead to clumping if dumped in one portion, creating localized hot spots that trigger exothermic hydrolysis of the cyano group to the amide, consuming reducing equivalents and elevating the impurity profile of the final amine hydrochloride. This exotherm, measured by a 1 mm diameter thermocouple at the solid-liquid interface in a 20 L vessel, can reach +18 °C above set point within 15 s if addition is uncontrolled—a thermal excursion that, while not a safety hazard in terms of runaway potential (adiabatic calorimetry gives an onset of nitrile decomposition only at 310 °C), nevertheless compromises product quality and requires rework.

    How the Nitrile Route Avoids a Genotoxic Impurity Flagged in the Aldehyde Pathway

    The sulfonylation step that installs the pyridin-3-ylsulfonyl group onto the pyrrole nitrogen employs pyridine-3-sulfonyl chloride hydrochloride. In the aldehyde-containing substrate, a side reaction generates trace (0.05–0.1%) levels of a ring-opened α,β-unsaturated aldehyde adduct from nucleophilic attack of chloride ion on the pyrrole ring, a structure flagged by in silico DEREK Nexus and Sarah Nexus (ICH M7) as a potential mutagenic impurity (Class 3 alert for Michael-reactive α,β-unsaturated carbonyl). The nitrile analog does not form this impurity because the cyano group deactivates the pyrrole C2 position more substantially toward chloride addition (Hammett σₚ for CN = +0.66 vs. +0.42 for CHO). As a result, control of this impurity is reduced to routine purge factor calculations (≤ 30% of the PDE of 1.5 µg/day) without the need to demonstrate a specific purge factor above 1000 in the downstream API step, simplifying the toxicological risk assessment package for regulatory filing.